chr1-160277198-C-A

Position:

• chr1-160277198-C-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The ENST00000368072.10(PEX19):​c.*2353G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0174 in 455,484 control chromosomes in the GnomAD database, including 451 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.041 (426 hom., cov: 32)
  • Exomes 𝑓: 0.0057 (25 hom.)
• Consequence: PEX19 ENST00000368072.10 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: -0.334

Genes affected

PEX19 (HGNC:9713): (peroxisomal biogenesis factor 19) This gene is necessary for early peroxisomal biogenesis. It acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. These disorders have at least 14 complementation groups, with more than one phenotype being observed for some complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS), as well as peroxisome biogenesis disorder complementation group 14 (PBD-CG14), which is also known as PBD-CGJ. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.96).
• BP6: Variant 1-160277198-C-A is Benign according to our data. Variant chr1-160277198-C-A is described in ClinVar as [Benign]. Clinvar id is 293195.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.139 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
PEX19	NM_002857.4	c.*2353G>T		3_prime_UTR_variant	8/8	ENST00000368072.10	NP_002848.1
PEX19	NM_001193644.1	c.*2361G>T		3_prime_UTR_variant	8/8		NP_001180573.1
PEX19	NR_036492.2	n.3152G>T		non_coding_transcript_exon_variant	7/7
PEX19	NR_036493.2	n.3176G>T		non_coding_transcript_exon_variant	7/7

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
PEX19	ENST00000368072.10	c.*2353G>T		3_prime_UTR_variant	8/8	1	NM_002857.4	ENSP00000357051	P1
PEX19	ENST00000472750.5	c.*3020G>T		3_prime_UTR_variant, NMD_transcript_variant	7/7	1		ENSP00000434633

Frequencies

GnomAD3 genomes AF: 0.0406 AC: 6163 AN: 151792 Hom.: 422 Cov.: 32

Gnomad AFR AF: 0.142

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.0128

Gnomad ASJ AF: 0.00

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00145

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.0255

Gnomad NFE AF: 0.000603

Gnomad OTH AF: 0.0273

GnomAD3 exomes AF: 0.00907 AC: 1162 AN: 128062 Hom.: 13 AF XY: 0.00749 AC XY: 525 AN XY: 70138

Gnomad AFR exome AF: 0.151

Gnomad AMR exome AF: 0.00719

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.00

Gnomad SAS exome AF: 0.000537

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.000633

Gnomad OTH exome AF: 0.00651

GnomAD4 exome AF: 0.00572 AC: 1737 AN: 303584 Hom.: 25 Cov.: 0 AF XY: 0.00437 AC XY: 755 AN XY: 172904

Gnomad4 AFR exome AF: 0.140

Gnomad4 AMR exome AF: 0.00748

Gnomad4 ASJ exome AF: 0.00

Gnomad4 EAS exome AF: 0.00

Gnomad4 SAS exome AF: 0.000636

Gnomad4 FIN exome AF: 0.0000809

Gnomad4 NFE exome AF: 0.000252

Gnomad4 OTH exome AF: 0.0109

GnomAD4 genome AF: 0.0407 AC: 6181 AN: 151900 Hom.: 426 Cov.: 32 AF XY: 0.0391 AC XY: 2902 AN XY: 74216

Gnomad4 AFR AF: 0.142

Gnomad4 AMR AF: 0.0128

Gnomad4 ASJ AF: 0.00

Gnomad4 EAS AF: 0.00

Gnomad4 SAS AF: 0.00125

Gnomad4 FIN AF: 0.00

Gnomad4 NFE AF: 0.000603

Gnomad4 OTH AF: 0.0270

Alfa AF: 0.00891 Hom.: 84

Bravo AF: 0.0452

Asia WGS AF: 0.00982 AC: 34 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Benign:1

Benign, criteria provided, single submitter

not provided

Breakthrough Genomics, Breakthrough Genomics

-

- -

Peroxisome biogenesis disorder 12A (Zellweger) Benign:1

Benign, criteria provided, single submitter

clinical testing

Illumina Laboratory Services, Illumina

Jan 12, 2018

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.96
CADD	Benign	0.35
DANN	Benign	0.34

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs9853; hg19: chr1-160246988;